AKAbdüllatif Karakaya

Abdüllatif Karakaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abdüllatif Karakaya has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Design and Synthesis of New Thiazole Derivatives for Alzheimer’s Disease Therapy as a Potential Cholinesterase Inhibitor; Toxicity Prediction and Molecular Docking Studies and Biological Evaluation

    by Mesut Işık, Gresa Halimi Syla, Abdüllatif Karakaya, Ulviye Acar Çevik, Nour El-Huda Daoud, Muhammet Fırat, Yüksel Öğünç Keçeci, Yusuf Özkay, Zafer Asım Kaplancıklı, Şükrü Beydemir

    In this study, thiazole derivatives 13–23 were synthesized as novel cholinesterase inhibitors. Their structures were elucidated using 1H-NMR, 13C-NMR, and elemental analysis techniques. The binding positions and efficiencies of the designed compounds on the enzyme were investigated through molecular docking studies, and the properties of ADMET were examined using computational methods. Cytotoxicity analyses of the synthesized compounds were performed to screen their inhibitory effects on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) in vitro. It has been determined that these compounds do not exhibit a significant cytotoxic effect on healthy endothelial cells. Although the compounds showed lower efficacy in AChE inhibition compared to the reference compound tacrine (IC50: 0.136 μM; KI: 0.46 ± 0.01 nM), they exhibited moderate inhibitory effects. Among these, compounds 16 and 23 were found to be the most potent AChE inhibitors, with IC50 values of 36.47 µM and 34.65 µM, and KI values of 22.20 ± 1.23 and 21.10 ± 1.58 µM, respectively, while compounds 15 and 20 were found to be the most potent BChE inhibitors, with IC50 values of 17.76 µM and 16.90 µM, and KI values of 14.10 ± 0.58 and 13.40 ± 0.48 µM, respectively, on other cholinesterases. These tested compounds can be considered potential candidates for further research in the treatment of Alzheimer’s disease (AD).

  • Thiazole: A promising scaffold in medicinal chemistry

    by Abdüllatif Karakaya, Emine Rana Bağci, Betül Kaya, Ulviye Acar Çevik, Zafer Asım Kaplancıklı

    Thiazole, a five-membered heterocyclic skeleton found in numerous commercially marketed drugs and various natural products, has gained significant attention in the field of medicinal chemistry. Thiazole derivatives have diverse therapeutic potential, including neuroprotective, antidiabetic, antioxidant, antimicrobial, anti-inflammatory, anticancer, antihypertensive, and antitubercular activities. The unique electronic and pharmacophoric features of the thiazole ring facilitate specific interactions with various biological targets. This review covers and highlights the most recently reported studies on thiazole-based derivatives with pharmacological potential.

  • Open Access

    Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents

    by Mesut Işık, Abdüllatif Karakaya, Ulviye Acar Çevik, Adem Necip, Hatice Esra Duran, Bilge Çiftçi, Yusuf Özkay, Zafer Asım Kaplancıklı, Şükrü Beydemir

    In this study, due to the side effect profiles and low efficacy of currently used inhibitors, novel benzimidazole-oxadiazole derivatives (6a–6e, 7a–7e) were synthesized as dual inhibitors of α-GLY and AR. Their structures were elucidated using 13C-NMR and 1H-NMR techniques. Their binding properties were investigated by molecular docking studies, and their ADME properties were screened in silico. AR and α-GLY inhibitory effects of the synthesized compounds were examined. The compounds were observed to exhibit partially similar inhibitory effects to the reference drug epalrestate (IC50: 0.78 nM; KI: 0.74 ± 0.0 nM) on AR inhibition. Among them, compounds 6a, 6b, and 6c showed the highest activity with KI values of 8.6 ± 0.4, 3.5 ± 0.3 and 6.3 ± 0.5 nM, respectively. Compounds 6a and 7e were found to have higher inhibitory activity against the α-GLY enzyme than the reference drug Acarbose (IC50: 128.4 µM; KI: 96.2 ± 5.7 µM) with KI values of 5.8 ± 0.4 and 7.9 ± 0.8 µM, respectively. Overall, the newly synthesized compounds demonstrated pronounced AR inhibitory activity and notable α-GLY inhibition. Nevertheless, further pharmacological and toxicity evaluations are required to confirm their therapeutic potential. Among the tested molecules, compounds 6a and 7e may therefore be considered potential candidates for further investigation as anti-diabetic agents.

  • Synthesis of New Hydrazone Derivatives, Characterization, Single Crystal X‐Ray, Antimicrobial, SEM , and DFT Studies

    by Hakan Ünver, Abdüllatif Karakaya, Ülküye Dudu Gül, Arzu Karayel, Ulviye Acar Çevik

    Fifteen new hydrazine derivatives were synthesized and structurally characterized using NMR ( 1 H NMR and 13 C NMR) spectroscopy techniques. Furthermore, the crystal structure of compound 1647 was figured out by the single crystal X‐ray analysis. The in vitro antimicrobial activity was reviewed against five species of pathogenic bacteria ( Escherichia coli [ATCC 25922], Serratia marcescens , Klebsiella pneumoniae [ATCC 13883], Staphylococcus aureus [ATCC 29213], Enterococcus faecalis [ATCC 2942]) and three fungal species ( Candida albicans [ATCC 24433], Candida krusei [ATCC 6258], and Candida parapsilopsis [ATCC 22019]). Compounds 1646 and 1647 with MIC of 1.95 μg/mL was found to be most active against E. coli (ATCC 25922). The presence of bromine or tert ‐butyl groups in the para position of the phenyl ring increased the antibacterial activity. It has been shown by SEM study that these compounds cause deterioration in the morphology of E. coli . Using DFT, the X‐ray geometry and model geometry of compound 1647 were optimized and compared in terms of both energy and geometry, and it was determined that they were conformers of each other with a difference of 0.11 kcal/mol.


  • Synthesis of Novel Benzofuran-Based Thiazole Hybrids and Investigation of Their Antioxidant and Anticholinesterase Activities

    by Betül Kaya, Zahra Maryam, Nour El-Huda Daoud, Emine Rana Bağci, Abdüllatif Karakaya, Tugba Ercetin, Ulviye Acar Çevik

    In this study, a novel series of benzofuran derivatives (2a-2k) were synthesized and the structures of the obtained compounds were elucidated by 1H NMR, 13C NMR and HRMS spectra. The compounds were investigated for their anticholinesterase and antioxidant potentials. The ferrous ion chelating activity of the compound 2g at 50 µM concentration was 68.25%, surpassing those of rutin and BHT (13.21% and 2.57%, respectively). Besides, according to DPPH radical scavenging activity assay, compound 2g exhibited the most potent antioxidant activity with an IC50 value of 30.14 ± 0.005 µM, when compared to standard gallic acid (IC50= 29.48 ± 0.014 µM). Furthermore, compounds 2d (10.33%) and 2i (20.17%), showed the highest inhibitory activity against AChE and BChE, respectively. Compound 2i exhibits important interactions with the active site of BChE, according to the in silico molecular docking study. Also, the in silico ADMET study revealed the desirable pharmacokinetic properties of compound 2i. Therefore, compounds 2g and 2i could be deemed as promising candidates for the designing dual functional antioxidant and butyrylcholinesterase inhibitors in the management of Alzheimer’s disease.


  • Open Access

    Microwave-assisted synthesis of pyrazoles - a mini-review

    by Abdüllatif Karakaya

    Heterocyclic compounds including pyrazole have a serious area in the field of medicinal chemistry and modern drug development studies. Pyrazole is a five-membered ring system containing two adjacent nitrogen atoms. Pyrazole attracts great attention due to its wide biological activity scale and potential in the development of new drug molecules. Traditional methods have been used in the general synthesis methods of pyrazole for a long time, but since these methods can be performed within certain limits, it is necessary to benefit from new and sustainable methodologies. In this review, the use and benefits of microwave (MW)-assisted techniques under the general title of green chemistry will be emphasized. The use of MW techniques stands out with its advantages such as increasing the efficiency of synthesis, obtaining selective products and preventing environmental pollution. The area of use of the MW method in pyrazole synthesis, synthesis mechanisms, organic synthesis methods and benefits are examined in this study. The MW method used in the synthesis of the pyrazole ring, which stands out with its bioactive diversity, will be encountered much more in the coming years.


  • Open Access

    Synthesis of novel thiazole derivatives against Alzheimer’s disease and investigation of their cholinesterase inhibition and antioxidant properties

    by Abdüllatif Karakaya, Tuğba Erçetin, Ulviye Acar Çevik, Yusuf Özkay

    In this study, 7 new thiazole derivatives were synthesized. Cholinesterase inhibition and antioxidant properties were examined to understand whether the synthesized compounds were anti-Alzheimer drug candidates. The antioxidant properties of these newly synthesized thiazole derivatives and their enzyme inhibition values for acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) were evaluated. According to the data, these substances inhibited the AChE and BuChE enzymes at deficient levels. Compound 2e showed the highest AChE inhibition effect with a value of 20.32 ± 0.005% at 50 µM concentration. Although high activity against BuChE was not observed, compound 2d was an exception with a value of 32.54 ± 0.021% at 50 µM concentration. Values that were comparable to the reference medication gallic acid were found when the antioxidant qualities were investigated using DPPH and ferric ion chelation studies. Ferrous ion-chelating and DPPH radical scavenging consistent with all of the previously reported information, the compounds’ antioxidant properties were very high, despite their modest cholinesterase enzyme inhibitory capabilities. In terms of AChE inhibition and antioxidant activity, respectively, compounds 2e and 2f were shown to be promising prospective agents among these compounds’.

  • Open Access

    Synthesis, Anticholinesterase and Antioxidant Activity of Thiosemicarbazone Derivatives

    by Betül Kaya, Ulviye Acar Çevik, Abdüllatif Karakaya, Tugba Ercetin

    In this research, we report the synthesis and evaluation of novel thiosemicarbazones as anti-Alzheimer’s agents. The structural clarification of the newly synthesized compounds was carried out by 1H NMR, 13C NMR, and MS analyses. According to the in vitro cholinesterase inhibition assay, compounds showed more inhibitory potential against AChE than BuChE. The in vitro antioxidant activity of the synthesized compounds was measured via two different methods. According to ferrous ion-chelating assay compound 2b demonstrated 5.26% activity when compared to BHT (2.57%). DPPH radical scavenging activity assay revealed that compound 2b showed the most potent antioxidant activity with an IC50 value of 43.91 ± 0.021μM. Among the synthesized compounds, compound 2b was found as the most potent antioxidant agent.


  • Open Access

    Synthesis of thiazole derivatives as cholinesterase inhibitors with antioxidant activity

    by Abdüllatif Karakaya, Zahra Maryam, Tugba Erceti̇n, Ulviye Acar Çevi̇k

    In the present research, we synthesized two unique series of thiazole compounds having 5-bromothiophene and 3-methylthiophene (2a-2f) in their structure. After that, spectroscopic methods were used to analyze the chemical compositions of the newly synthesized molecules. Then in vitro evaluation was done to determine acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activity of the synthesized compounds using galantamine as reference standard. The compounds’ antioxidant properties were assessed using DPPH radical scavenging and ferrous ion-chelating techniques. The results of the study showed weak anticholinesterase activity against AChE and BuChE enzymes for all the final compounds. The synthesized analogs also showed significant DPPH radical scavenging activities with IC50 values in the range of 29.16 ± 0.009 to 33.09 ± 0.004 µM (for DDPH) incomparison to standard gallic acid with IC50 = 31.13 ± 0.008 µM (for DDPH). Especially, compound 2c showed the best antioxidant activity with IC50 value of 29.16 ± 0.009 µM.